FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

3187811000001107: Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25749501000001112 Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65943301000001119 Xatral 2.5mg tablets (Sanofi) 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Is a Alfuzosin 2.5mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Is pack of Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has AMP Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has specific active ingredient Alfuzosin hydrochloride true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xatral 2.5mg tablets (Sanofi-Synthelabo Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start